{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-22-157512","form_type":"8-K","ticker":"DFTX","cik":"0001813814","company_name":"Definium Therapeutics, Inc.","filed_at":"2022-05-23T23:59:59+00:00","discovered_at":"2026-05-14T18:04:02.435486+00:00","generated_at":"2026-06-25T08:19:38.412469+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"MindMed appoints Schond Greenway as CFO, effective May 23, 2022","bullets":["Schond Greenway named CFO effective May 23, 2022; previously CFO at Avalo Therapeutics.","Base salary of $400,000; eligible for discretionary annual cash bonus with 40% target.","Received option for 1,650,000 shares (4-yr vest) and RSU for 1,270,000 shares (4-yr vest).","Greenway brings experience from Avalo, Mesoblast, Halozyme, and investment banks."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-22-157512","json":"https://secwatch.observer/filing/0001193125-22-157512.json","markdown":"https://secwatch.observer/filing/0001193125-22-157512.md","text":"https://secwatch.observer/filing/0001193125-22-157512.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1813814/000119312522157512/0001193125-22-157512-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1813814/000119312522157512/d320568d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-25T08:19:38.412469+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"86189264f3","claim":"Schond Greenway was appointed as Chief Financial Officer at Definium Therapeutics, Inc..","evidence_excerpt":"On May 23, 2022, Mind Medicine (MindMed) Inc. (the “Company”) announced the appointment of Schond Greenway as the Company’s Chief Financial Officer, effective May 23, 2022","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1813814/000119312522157512/0001193125-22-157512-index.htm","confidence":1.0,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Chief Financial Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}